Vanlev omapatrilat: Completed Phase III trial

Bristol-Myers Squibb Co. (BMY), Princeton, N.J.
Product: Vanlev omapatrilat
Business: Cardiovascular
Therapeutic

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE